»RELATED: New selfie app could screen for pancreatic cancer
In fact, the authors wrote, "Long-term use of aspirin showed 24 percent to 47 percent significant reduction on major cancers in the [gastrointestinal] tract."
Additionally, they were able to link aspirin with the reduction of some non-gastrointestinal cancers, such as leukemia, lung and prostate cancer. However, the correlation was not found with breast, kidney or bladder cancer.
Why does aspirin have this effect?
Aspirin can reduce tissue growth, which can be precursors to certain cancers, the researchers said.
Previous studies have noted that it "has emerged as the most likely NSAID for use in chemoprevention because of its known cardiovascular benefit and available safety and efficacy data."
Analysts said they believe their findings can reduce the chances of developing cancer, so they are “pursuing prospective investigations for further confirming the findings.”
»RELATED: 7 surprising things that can increase your risk of cancer